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Human co-infections of helminths and malaria parasites are a common phenomenon in areas where 
malaria is endemic, more so in Sub-Saharan Africa were tissue-dwelling helminths, such as 
Trichinella spp are also endemic. However, the immune-pathogenesis of the diseases when there 
is co-infection remains obscure, hence there is a need to understand the host immune responses 
induced during co-infection. This study therefore aimed at investigating the host cytokine and 
haematological profiles in Sprague-Dawley rats experimentally co-infected with T. zimbabwensis 
and Plasmodium berghei. A 42 day study was done, where 168 male Sprague-Dawley rats (90-
150g) were divided into four separate experimental groups, control (n=42); malaria infected 
(n=42); Trichinella infected (n=42); and co-infected group (n=42). Trichinella induction using 
Trichinella zimbabwensis muscle larvae (500) per os was done on day 0, while malaria induction 
using Plasmodium berghei parasitized RBCs 1 x 105 was injected intraperitonally on day 28 of the 
study. Animals were sacrificed at day 0, 7, 14, 21, 35 and 42 post-infection for blood and sera 
collection. Plasmodium berghei parasitaemia, Trichinella parasite load, haematology parameters 
and serum levels of TNF-α, IL-4, IL-6 and IL-10 were measured. Results for % parasitaemia 
showed that the P. berghei (MI) group reached the peak at day 6 with 66.77% ± 4.63% while the 
P. berghei and T. zimbabwensis (CI) reached its peak on day 7 with 69.17% ± 3.80%.). Trichinella 
parasite load results showed that the adult worms in the T. zimbabwensis group (MI) had a mean 
of 18.50% ± 8.06% on day 7 p.i. while the co-infected with P. berghei and T. zimbabwensis (CI) 
develop a mean of 15.00% ± 6.44%. On day 42, the muscle larvae (ML) in the T. zimbabwensis 
group (MI) increased exponentially with a mean of 97.37% ± 20.6% compare to the P. berghei 
and T. zimbabwensis group (CI) 71.63% ± 17.11%. Cytokines levels in the serum showed 
significant concentrations (P<0.001) of tumour necrosis factor-alpha (TNF-α) on day 7 p.i. in the 
P. berghei group (MI), and significant concentrations (P<0.001) of interleukin-10 (IL-10) was also 
observed on day 7 p.i. in the P. berghei group (MI) respectively. IL-4 and IL-6 did not yield result 
as the serum concentrations were below the lowest standard of the assay protocol, these could be 
due to some other components of the assays such as the proprietary monoclonal antibody pairs that 
makes them less sensitive. 
In conclusion, we observed that P. berghei and T. zimbabwensis (CI) group showed rapid 
development and increased parasitaemia than rats in the P. berghei (MI) group. Therefore, rats co-
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infected with P. berghei and T. zimbabwensis may aggravate the course of disease in the host by 
increasing parasitaemia, but elevated IL-10 plays a crucial role in the suppression of hepatic 
pathology in the host. Moreover, malaria conferred protection to T. zimbabwensis infection, as 
demonstrated by reduced worm counts in the co-infected (CI) group. 
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According to the World Health Organization (WHO), malaria is one of the most serious infectious 
diseases of humans with over 250 million clinical cases every year worldwide (Murray et al., 
2012). It is the major cause of mortality and morbidity especially in developing countries due to 
the absence of vaccine, parasite resistance to the available anti-malarial drugs, anopheline 
mosquitoes resistance to insecticide spraying and the poor socio-economic situation (Ter Kuile et 
al., 2003). Due to the increasing parasite drug-resistance and mosquito insecticide-resistance over 
the past years, malaria still remains endemic in many parts of the world (Onkoba et al., 2015a). 
The burden of malaria is aggravated by the high number of malaria co-infections with other 
infectious diseases (Onkoba et al., 2015a; Ademola and Odeniran, 2016). In 2010, it was estimated 
that about 3.3 billion people were at risk of malaria and about 1,238,000 deaths were recorded that 
year (Murray et al., 2012). In areas where malaria is endemic, it is the norm that Plasmodium-
infected people also suffer from a concurrent helminth infection which has been shown repeatedly 
to modulate the immune system of their host in order to survive (Ateba-Ngoa et al., 2015).  
Trichinellosis is an emerging and re-emerging zoonotic disease caused by a parasitic tissue-
dwelling nematode of the genus Trichinella. The parasite is acquired by the ingestion of raw or 
inadequately cooked meat products containing muscle larvae of the Trichinella parasite (Murrell 
and Pozio, 2011). Geographical distribution is worldwide and Trichinella spp have been reported 
to occur in 66 countries and infects an estimated 11 million people (Yang et al., 2010a). The 
geographical distribution of which overlaps with malaria in endemic areas of Tanzania, Uganda, 
Kenya, Ethiopia, Zimbabwe, South Africa and Mozambique (Onkoba et al., 2015a). According to 
Pozio (2007), it has also been reported that Trichinella spp. infections in animals and in humans 
are found in ten sub-Sahara Africa countries (Pozio, 2007). From the period of 1986–2009, about 
65 818 human trichinellosis cases and 42 deaths were reported worldwide and during that period 
only one sub-Sahara African country reported human trichinellosis, contributing 0.04% and 3.6% 
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of human trichinellosis and mortality worldwide, respectively (Murrell and Pozio, 2011; 
Mukaratirwa et al., 2013).  
The disease is manifested with targeted clinical signs and symptoms of variable intensity, 
depending upon the extent of invasion (Kociecka, 2000). Trichinella species exhibit a 
cosmopolitan distribution infecting mammals exceptionally with scavenging and cannibalistic 
behavior (Matenga et al., 2006). Trichinella zimbabwensis, a non-encapsulated species, is the most 
prevalent Trichinella spp in southern Africa (Mukaratirwa et al., 2013). Trichinella zimbabwensis 
complete its life cycle independently of whether or not the host is warm-blooded or cold-blooded 
(Mitreva and Jasmer, 2006).  
The production of cytokine (tumor necrosis element alpha [TNF-α] and gamma interferon [IFN-
γ]) in malaria infections appears to be indispensable for the inhibition of parasitaemia and 
stimulation of phagocytosis to increase clearance of parasitized erythrocytes (Lyke et al., 2004). 
High plasma concentrations of pro-inflammatory cytokines corresponding to TNF-α and IFN-γ 
and a reduction of anti- inflammatory cytokine, IL-10, may be accountable for pathophysiological 
and clinical outcomes of malaria (Clark and Cowden, 2003). Pro-inflammatory cytokines are 
secreted following the release of parasite antigens in the course of the bursting of parasitized red 
blood cells (pRBCs) (Clark et al., 2003).  
Epidemiological studies have proven that the largest burden of malaria infections is felt by 
communities living in poor regions of developing countries (Shankarkumar et al., 2011). In these 
areas, the excessive prevalence of soil-transmitted helminthic infections has also been documented 
(Onkoba et al., 2015a). This results in co-infections, multi-parasitism or polyparasitism (Supali et 
al., 2010). Co-infection with distinctive pathogens is a common occurrence which is able to alter 
the development of diseases and these relationships are complicated, because the immune response 
can control survival and proliferation of the pathogen and be accountable for tissue damage (Furze 
et al., 2006). Also, co-infections with malaria often complicate and increase the severity of 
parasitic diseases (Brooker et al., 2006a; Ademola and Odeniran, 2016). The effect of helminths 
on concurrent infection with malaria is of designated interest, given their prevalence in human 
populations (Furze et al., 2006). However, the immune pathogenesis of the diseases when there is 
co-infection remains obscure despite the need to understand the host immune responses induced 
during co- infection.  
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1.2 Aim and Objectives 
Therefore, this study was aimed at investigating the cytokine responses in experimental animal 
paradigms co- infected with Trichinella zimbabwensis and Plasmodium berghei. 
The specific objectives of the study are to: 
a. Determine the host cytokine responses induced during co-infection with Trichinella 
zimbabwensis and Plasmodium berghei in Sprague-Dawley rats 
b. Determine the heamatological profiles during co-infection with Trichinella zimbabwensis 
and Plasmodium berghei in Sprague-Dawley rats 
c. Determine the level of parasitaemia in Sprague-Dawley rats co-infected with Trichinella 
zimbabwensis and Plasmodium berghei 
Research question 
a. What is the level of host cytokine response in Sprague-Dawley rats during co-infection 
with Trichinella zimbabwensis and Plasmodium berghei? 
b. What is the level of heamatological profiles during co-infection with Trichinella 
zimbabwensis and Plasmodium berghei in Sprague-Dawley rats? 
c. What is the level of parasitaemia load in Sprague-Dawley rats during co-infection with 
Trichinella zimbabwensis and Plasmodium berghei? 
 
Hypotheses 
a. Co-infection of Trichinella zimbabwensis and Plasmodium berghei in Sprague-Dawley 
rats does not influence the level of cytokine. 
b. Co-infection of Trichinella zimbabwensis and Plasmodium berghei in Sprague-Dawley 
rats does not influence the level of heamatological profiles. 
c. Co-infection of Trichinella zimbabwensis and Plasmodium berghei in Sprague-Dawley 





2.0 CHAPTER 2: LITERATURE REVIEW 
 
2.1 Introduction  
 
Malaria remains one of the most widespread infectious ailments of our time (Delves et al., 2012). 
The five recognized Plasmodium species that cause human malaria are Plasmodium vivax, 
Plasmodium ovale, Plasmodium falciparum, Plasmodium malariae and Plasmodium knowlesi 
(Lopes et al., 2014), although P. falciparum is the most common in Sub-Saharan Africa, whereas 
P. malariae is sporadic worldwide (Pow, 2012). Female mosquitoes of the genus Anopheles 
transmit single-cell eukaryotic plasmodium parasites, which are causative agent of malaria 
(Hammerschmidt-Kamper, 2012). Malaria parasites cause anaemia via haemolysis and elevated 
splenic clearance of infected and uninfected red blood cells (Marcelline, 2015). In humans, the 
malaria parasites develop and multiply first within the liver cells and then within the red blood 
cells (RBCs), the stages of the parasite during the erythrocytic cycle are those that cause the clinical 
symptoms of malaria (Sahu et al., 2016a).  
2.1.1 The Plasmodium life cycle 
 
The plasmodium life cycle is relatively complex and it involves a number of highly specific 
interactions with well-defined types of host cell which is found both in the mosquito vector, which 
is the primary host, and a place of sexual reproduction (gametogony) and in the vertebrate host, 
where the asexual replication (schizogony) takes place (Blandine et al., 2004). Malaria is acquired 
through a bite of an infected female Anopheles mosquito, which injects the sporozoites into the 
host’s dermis. The sporozoites are then carried in the blood stream to the hepatocytes in the liver. 
They mature to tissue schizonts, which later release merozoites into liver sinusoids. The 
erythrocytic cycle starts when the mature tissue schizonts invade the red blood cells (RBC) 
leading to the formation of ring forms or trophozoites. However, in case of P. vivax and P. 
ovale, some sporozoites may go into hibernation, (the cryptobiotic phase), giving rise to 
hypnozoites. The hypnozoites can lie dormant for months or years and upon reactivation they 
cause clinical relapse (Clark and Schofield, 2000; Mackintosh et al., 2004). The trophozoites 
formed subsequently develop into schizonts that later release a new generation of merozoites. The 
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parasitized red blood cells eventually rupture to release a new generation of merozoites into the 
blood stream to repeat the same cycle. The sexual cycle in the vector is completed by 
differentiation of some merozoites into male and female gametocytes (Mackintosh et al., 2004). 
The malaria parasite has been shown to have complex metabolic processes such as utilization of 
amino acids derived from haemoglobin and detoxification of haeme. The enzyme plasmodium 
aldolase has been identified as one of the enzymes of parasite anaerobic glycolysis (Clark and 
Cowden, 2003). Reports indicate that the parasites increase the permeability of red blood cell to 
acquire nutrients, yet maintaining the red blood cell structure intact for at least 48 hours 
(Mackintosh et al., 2004). The parasite ingests haemoglobin from RBCs to form a food vacuole 
where haemoglobin is degraded, releasing haem moeity. The toxic haeme is in turn detoxified by 
haeme polymerase and sequestrated as haemozoin (malaria pigment). Many of the antimalarial 
drugs act by inhibiting haeme polymerase thereby causing accumulation of toxic haeme moeity 
(Mackintosh et al., 2004). Malaria manifestations vary and depend on age and the acquisition of 
immunity, host and parasite genetic polymorphisms and Plasmodium spp. (Lyke et al., 2004). 
Variations in human cytokine responses and their link to malaria disease manifestations is subject 
of much debate (Lyke et al., 2004), although a common imbalance in the secretion of pro-
inflammatory and anti-inflammatory cytokines based on malaria precipitated hypoxia has been 
observed (Clark and Cowden, 2003). The basic life cycle of all the Plasmodium species is similar 




Figure 1: The Plasmodium life cycle (Portugal et al., 2011). 
2.1.2 Pathogenesis of malaria  
 
The pathogenesis of malaria is complex and entails immunologic and non-immunologic 
mechanisms (Miller et al., 2002). Although it is generally accepted that severe malaria is the 
outcome of alterations in various tissues and organs. These alterations often lead to metabolic 
acidosis and localized ischemia (Angulo and Fresno, 2002). Previous studies observed that parasite 
factors can contribute to the severity of disorder, as is apparent from their ability to result in 
production of pro-inflammatory cytokines (Chotivanich et al., 2000). More so, much evidence has 
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been collected that points to glycosylphosphatidylinositols from Plasmodium as essential 
pathogenic compounds because of their ability to induce TNF-α and IL-1. This view is strongly 
supported by means of the fact that toxicity of malaria parasite extracts can be neutralized by 
monoclonal antibodies in experimental units (Angulo and Fresno, 2002). It is important to note 
that the presence of antiglycosylphosphatidylinositol antibodies in the serum of patients may only 
provide safety in opposition to clinical signs of malaria (Clark and Schofield, 2000). IL-12 and/or 
IFN-γ link to involvement with the pathogenesis of CM (celebral malaria) comes from studies with 
knockout mice infected with P. berghei ANKA and IRF-1−/− mice infected with P. berghei 
(Senaldi et al., 1999). Although in cases where IL-12 and IFN-γ show a dominant pathological 
role, a protective outcome has been verified for IL-10 (Angulo and Fresno, 2002). It is important 
to also note that the administration of murine IL-1, which is a pro-inflammatory cytokine, also 
helps in the protection of CM, although various pro-inflammatory cytokines that obviously play a 
role in CM could also be redundant, making it difficult to unequivocally assign to them a 
pathogenic function in all clinical instances (Alghasham and Rasheed, 2014).  
2.1.3 Global epidemiology/Economic impact of malaria 
 
Malaria has a global distribution and consequential health burden. The spatial limits of its 
distribution and seasonal activity are sensitive to climate factors, as well as the local capacity to 
control the disease (Caminade et al., 2014). Malaria disease is present in several regions of the 
world like Africa, South-East-Asia and South-America and people living in Sub-Saharan Africa 
have the highest risk of getting infected by the disease (Hammerschmidt-Kamper, 2012). In total, 
104 countries are endemic to malaria disease with substantial geographic disparities (Bhutta et al., 
2014). It is estimated that 81% of reported cases and 91% of deaths due to malaria in 2010 occurred 
in the Sub-Saharan Africa region, and about 86% of malaria incidence involved children under the 
age of five years and pregnant women particularly in the first pregnancies are probably the most 
severely affected ones (Bhutta et al., 2014).  
Malaria is caused by a protozoan parasite from the genus Plasmodium, which is transmitted via 
the bite of a female Anopheles mosquito. There are four species of Plasmodium causing human 
malaria. Plasmodium falciparum occurs predominantly in sub-Saharan Africa and is responsible 
for the majority of mortality and burden due to malaria. Plasmodium vivax is the second most 
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important species, and its occurrence is particularly prominent in Asia. The other two species are 
Plasmodium malariae and Plasmodium ovale (Matthys, 2006). The severity of P. falciparum 
malaria is as a result of organism's ability to invade young and old red blood cells, which is not 
characteristic of the other Plasmodium species (Menkir and Lema, 2014). Moreover, lack and 
absence of malaria prevention and control services, health services deterioration, population 
movement, desert fringes and highlands have contributed to the huge malaria cases and deaths 
(Menkir and Lema, 2014). In addition, ideal climatic conditions which are exacerbated by some 
of the world's most efficient malaria vectors, such as Anopheles gambiae, Anopheles arabiensis 
and Anopheles funestus and natural disasters such as El-Nino and tsunamis (Menkir and Lema, 
2014). 
It is not a debate that nations with high malaria incidence exhibit low levels of economic 
development (Barofsky et al., 2011). Moreover, to severe health consequences, nations with high 
malaria incidence also exhibit low levels of economic development, malaria affects human capital 
and income in several ways, for example, infection during childhood causes cognitive impairment 
and can reduce educational outcomes or labour productivity (Barofsky et al., 2011). Malaria in the 
community or household can reduce overall investment and income available for schooling. In 
addition to the immediate effects of malaria on health, there is evidence that malaria exposure 
during infancy and childhood can have detrimental effects on long-term cognitive development 
(Barofsky et al., 2011). A 2006 systematic review of 18 studies concluded that P. falciparum 
malaria in childhood affects short- and long-term neurocognitive performance, including attention, 
memory, visio-spacial skills, and language functioning (Kihara et al., 2006). Aside from the 
population health impact of malaria reduction, there is a large body of work that looked at the 





Figure 2: Geographical distribution of malaria and areas at risk of transmission (WHO 2011). 
2.1.4 Diagnosis of malaria  
 
Diagnosis of malaria is an essential component for effective disease management and in decreasing 
mortality and morbidity (Bronzan et al., 2008). Although diagnosis is complicated by the fact that 
acquired immunity to malaria can result in asymptomatic infections as no existing malaria 
diagnostic test can distinguished malaria illness from parasitaemia with concomitant fever of 
another cause (Bronzan et al., 2008). Several methods are used in detecting malaria parasites 
within peripheral blood since diagnosis of malaria is situated on clinical criteria (Williams et al., 
2008). Clinical diagnosis based on clinical symptoms is the most commonly used method, and it 
is the basis for self-treatment and least expensive. However, the overlapping of malaria signs with 
different tropical ailments impairs its specificity and therefore encourages the indiscriminate use 
of anti-malarials for managing febrile conditions in endemic areas (Wongsrichanalai et al., 2007). 
This practice was in the past inexpensive and well-tolerated when anti-malarials were still effective 
(Biritwum et al., 2000).  
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There is a variation in the accuracy of clinical diagnosis depending on the level of endemicity, 
malaria season, and age group and no single clinical algorithm is a universal predictor (Mwangi et 
al., 2005). Only in children in hyper-endemic areas can clinical diagnosis determine the medication 
resolution (Chandramohan et al., 2002). In this situation, majority of the populations are 
chronically parasitemic, and could also be concomitant with other febrile causing illnesses 
(Wongsrichanalai et al., 2007). Accurate diagnosis can be done traditionally with the aid of using 
microscopic examination of blood smear for Plasmodium spp. In 1904, Gustav Giemsa introduced 
Microscopic examination of Giemsa-stained blood smears which has subsequently become the 
gold standard of malaria diagnosis (Wongsrichanalai et al., 2007). Giemsa staining and 
microscopic examination of blood smeared slides is known to be the most suitable diagnostic 
instrument for malaria control considering the fact that it is inexpensive to perform, and it has the 
capability to differentiate malaria species, and quantify parasites. In the age of high-quality light 
emitting diode (LED) illumination and solar battery chargers, microscopy has turn out to be more 
viable in remote areas. Improving diagnostic accuracy in malaria control systems can be both 
technically and financially challenging (Biritwum et al., 2000). Current rapid diagnostic tests 
(RDT) promote ease-of-use and safety in comparison to the earlier assays of the early and mid-
1990s. RDT use, especially in developing countries, has escalated for the past few years. Most 
commonly used RDTs only detect P. falciparum, however, RDTs that distinguish P. falciparum 
from the three non-falciparum species are available. Several factors in the manufacturing process 
as well as environmental conditions may affect RDT performance (Bell et al., 2006; Mboera et al., 
2013). Also other methods like the antigen detection and polymerase chain reaction (PCR) are 
being used in both endemic and non-endemic arrears depending on the type of infection and the 
severity of the infection (Bronzan et al., 2008). Although, in malaria endemic areas, reliably 
establishing parasitaemia and excluding other causes of severe disease can be difficult (Drakeley 
and Reyburn, 2009). 
2.1.5 Control and treatment of malaria  
 
Malaria is the world's most established parasitic disease and against which effective control 
measures are urgently needed (Angulo and Fresno, 2002). The control and prevention method of 
malaria includes use of long lasting insecticidal nets (LLINs) to individuals with risk of infection 
and indoor residual spraying (IRS), and use of anti-malarial drugs (Fairhurst et al., 2012). 
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Artemisinin-based combination therapy (ACT) is recommended for areas with drug resistance or 
more deadly malaria strains (Organization and Control, 2010). National malaria programs recorded 
that ACT distribution increased from 2 million in 2004 to 73 million in 2008 (Aregawi et al., 
2009). But less than 15% of children in Africa received ACT in 2008 and access to other types of 
anti- malarial therapy is also limited (Aregawi et al., 2009). Intermittent preventative method (IPT) 
is recommended for population groups in areas of excessive transmission who are particularly 
vulnerable to Plasmodium infection and its consequences, particularly pregnant women and 
infants. The goals postulated by the Global Malaria Action Plan (Malaria, 2008) were that the 
interventions should reduce the numbers of malaria cases and deaths per capita by 50% or more 
between 2000 and 2010 and by 75% or more between 2000 and 2015. Currently there are five 
ACTs recommended for use; artemether-lumefantrine, artesunate-amodiaquine, artesunate-
mefloquine, artesunate-sulfadoxine pyrimethamine and dihydroartemisinin-piperaquin of which 
only one (artemether-lumefantrine) is available as a child-friendly taste-masked formulation 
(Hemingway et al., 2016). The primary hindrance to the control of malaria transmission through 
administration of effective anti-malarial drugs in Sub-Saharan Africa is that medical facilities are 
limited, poorly equipped and poorly funded, despite being the epicentre of malaria infection 
(WHO, 2008). 
2.1.6 The immune system and Plasmodium spp interaction 
 
Efforts have been devoted to the study of the characteristics of immune responses against 
Plasmodium spp. It is now generally accepted that innate immunity plays a crucial role in clearing 
Plasmodium spp infection from parasitized hosts. There is growing evidence that the increased 
production of pro-inflammatory cytokines during immune or inflammatory responses can exert 
powerful influences on the central nervous system (CNS). Cytokines play a role in the 
pathogenesis of numerous disorders including infection, autoimmune disease, stroke, trauma, and 
neuro degenerative disease (Janssen et al., 2010). Most of the elimination of Plasmodium spp. 
often occurs in the spleen under normal circumstances, although the liver has been proven to 
function as an alternative clearing site (Angulo and Fresno, 2002). The splenic response is 
complicated and involves distinctive tissue changes that provoke alterations in blood flow through 
the organ (Angulo and Fresno, 2002). These changes prevent the access of infected erythrocytes 
to splenic tissues in which the immune response is going on until armed effector cells are produced. 
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Splenic marginal zone macrophages, a phagocytic subset of macrophages at the interface between 
red and white pulp, seem not to be involved in eradicating infected erythrocytes (Angulo and 
Fresno, 2002). This task is apparently assumed by macrophages of the red pulp (Angulo and 
Fresno, 2002). Recent work has shown that P. chabaudi infection in T-cell-deficient mice is 
exacerbated early and these results fit well with data ascribing early production of gamma 
interferon (IFN-γ) and tumor necrosis factor alpha (TNF-α) both to splenic/T lymphocytes and to 
natural killer (NK) cells (Choudhury et al., 2000).  
2.1.7 Production of cytokines and their roles in Plasmodium spp infection 
 
Early production of IFN-γ is very crucial in resistance against malaria infection. In support of this 
view, analysis of IFN-γ mice infected with P. chabaudi showed a critical role of IFN-γ in immunity 
against this pathogen, although the production of parasite-specific immunoglobulins was not 
affected (Angulo and Fresno, 2002). According to reports, it has been reported that IFN-γ 
responsive factor (IRF-1) in mice infected with P. berghei showed was related to lower mortality 
in wild-type mice, these results are therefore an indication that IFN-γ and/or other molecules under 
the control of IRF-1 play a role in the pathological outcome of the diseases. IL-12 appears to be 
critically linked to or to act through IFN-γ production, thereby allowing an early and sustained 
Th1 response (Angulo and Fresno, 2002). 
 
In addition to its role in resolving primary infection, IL-12 has been shown to be required for the 
production of a protective immunoglobulin G2a (IgG2a) antibody (Su and Stevenson, 2002). A 
similar picture to that depicted for IFN-γ emerged for the role of TNF-α in early responses against 
Plasmodium. Treatment with anti-TNF-α monoclonal antibody resulted in a tendency toward 
longer times for parasite clearance. Interestingly, this effect is associated with reduced levels of 
IFN-γ, supporting the general view of an association between the ability to produce high levels of 






2.1.8 Impact of IL-10 on the regulation of host responses during malaria 
 
Increased levels of pro-inflammatory cytokines such as IFN-γ, IL-1, TNF-α and IFN-γ -induced 
protein (IP)-10 (CXCL10) form part of an early host response to the parasite and these cytokines 
have also been associated with severe anaemia, hyperglycemia and cerebral malaria in P. 
falciparum infection (Armah et al., 2007; do Rosario and Langhorne, 2012). In order to limit 
excessive damage to the host, control of this inflammatory response is of a necessity. One way of 
controlling or down-regulating host immune responses is through the cytokine IL-10 which is a 
key cytokine that has been proven to have an essential regulatory function in establishing this 
balance in malaria (O'Garra et al., 2008). IL-10 has recently been described as the strongest 
predictor of disease in endemic regions (Sinha et al., 2010) and considered as a biomarker for 
inflammatory placental malaria (do Rosario and Langhorne, 2012). Recently, it has been proven 
in an area of low malaria endemicity that even though the magnitude of IFN-γ response reduces 
enormously with time, the IL-10 response of peripheral blood mononuclear cells (PBMC) was 
stably maintained without a tremendous decline over a minimum of 6 years (Wipasa et al., 2011). 
High production of IL-10 has been found in patients protected from severe anaemia (Ouma et al., 
2008; do Rosario and Langhorne, 2012) and in sera of women with pregnancy suffering from 
asymptomatic malaria (Wilson et al., 2010). Nevertheless, not all of the studies are in line with the 
idea that IL-10 suppresses or controls severe malaria, as excess levels of IL-10 have also been 
associated with high disease severity in humans, including cerebral malaria, anaemia and 
respiratory distress (Ong’echa et al., 2008; Ayimba et al., 2011). Again, IL-10 induced through 
co-infecting non-lethal malaria parasite in conjunction with P. berghei ANKA can hinder 
experimental cerebral malaria (ECM) (Niikura et al., 2010).  
In similar way, infection of non-human primates with P. cynomolgi, the highest degree of anaemia 
was associated with robust pro-inflammatory responses and the quantity of IL-10 correlated with 
higher haematocrit values (Praba-Egge et al., 2002; do Rosario and Langhorne, 2012). IL-10 
appears to hinder parasite clearance, at the same time down-regulating pro-inflammatory response 
and avert hepatic pathology (Couper et al., 2008). Additionally, IL-10 has also been known to 
promote hyper-parasitaemia of P. chabaudi adami (Weidanz et al., 2005). Furthermore, 
CD11bhighLy6C+ inflammatory monocytes that migrate from the bone marrow to the spleen in the 
14 
 
course of P. chabaudi infection produce not only pro-inflammatory cytokines such as IL-6 and 
TNF-α, but also IL-10 (Sponaas et al., 2009).  
2.2 Trichinellosis 
 
Nematodes of the genus Trichinella are some of the most widespread zoonotic pathogens in the 
world and the impact of parasitic zoonosis on health, the economy and society has increased in 
recent years (Kurdova-Mintcheva et al., 2009). Despite concerted efforts to control trichinellosis, 
the disease remains a threat in many countries especially developing countries (Murrell and Pozio, 
2011; Mukaratirwa et al., 2013). Infection has been detected in domestic and wild animals of all 
continents, aside from Antarctica, which is one of the places where there is not any report of the 
parasite (Pozio, 2007). The risk of future human T. zimbabwensis infection in sub-Saharan Africa 
is increasing due to poverty, food insecurity, climate change and failure of veterinary controls and 
surveillance (Gottstein et al., 2009; Mukaratirwa et al., 2013; Onkoba et al., 2015b). Moreso, 
globalization has exacerbated the risk through increased movement of people, wildlife and 
livestock in and out of T. zimbabwensis endemic zones of southern Africa (Mukaratirwa et al., 
2013; Onkoba et al., 2015b). Trichinella spp. plays a vital role in the suppression of the host 
immune response and other immune-related pathologies (Bai et al., 2012).  
2.2.1 Life cycle of Trichinella spp 
 
The life cycle of Trichinella spp involves mammalian hosts, together with humans and is known 
to complete all stages of development in one host (Wu et al., 2009). Although only humans and 
non-human primates become clinically affected, transmission from one host to another can only 
occur by consumption or ingestion of contaminated muscle which is infected with the encysted 
larval stage of parasite (Wu et al., 2009). The ingested larvae invade the small intestine, where 
they undergo development into adult worms within 1-2 weeks in the intestine causing irritation 
and mild abdominal cramping or even diarrhea (Wu et al., 2009). The adult male and female mate 
and produce newborn larvae (NBL) which leave the intestine and migrate through the circulatory 
system and penetrate the striated muscle tissue and reside in the nurse-cells causing muscle pains, 
fever, periorbital edema, eosinophilia, occasional CNS or cardiac damage, hypoglycaemia and 
acute renal failure (Gottstein et al., 2009). In the muscle, Trichinella larvae mature to become 
15 
 
infective to another host and adult worms continue to produce larvae in the intestines for several 
weeks before they are expelled (Gottstein et al., 2009). Once larvae encyst in musculature, they 
can remain alive and infective for years (Gottstein et al., 2009). The number of larvae ingested 
determines the severity of the disease (Bruschi and Murrell, 2002). Trichinella spp maintain their 
life cycle only when another animal ingest muscle tissue containing the encapsulated or non-
encapsulated larvae (Bruschi and Murrell, 2002). 
 
Figure 3: Trichinella sp. life cycle (Gottstein et al., 2009). 
2.2.2 Immune response during Trichinella infection 
 
During Trichinella infection, the intestinal mucosa is the first barrier to encounter parasites, and 
mucosal immunity is prone to be essential in protecting the host against Trichinella infection. 
There is evidence that the intestinal mucosa of infected animals produces antibodies specifically 
against T. spiralis, and the production of mucosal IgA mediates the protective immunity (Yang et 
al., 2010b). Studies have also shown that attenuated Salmonella typhimurium is a strong vector for 
oral delivery of heterologous antigens to the immune system, resulting in long-lasting mucosal and 
systemic responses and thus providing an effective platform technology for the design of novel 
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vaccination strategies (Yang et al., 2010b). Helminthic parasite infection could elicit Th2 
responses against the host, particularly at the larval stage. Trichinella spiralis can also activate 
host IL-4 and IL-5 cytokines, IgE levels, and eosinophilia (Park et al., 2011). Studies regarding 
the immune evasion mechanisms of Trichinella infection have been previously reported, in 
particular, IL-10 operates as an inflammation regulator in cases of intestinal and muscle 
trichinellosis in mice (Park et al., 2011).  
The essential features of immune responses to Trichinella are IgE production and eosinophilia 
(Watanabe et al., 2005). The IgE production has been described with the aid of induction of T 
helper (Th)2 cells that produce cytokines such as interleukin (IL)-4 and IL-13, which are key 
molecules for identifying B-cell differentiation to IgE-producing cells (Watanabe et al., 2005). The 
IgE antibody is effective in the intestinal lumen which is transported from plasma and the 
suppression of IgE production was developed in rats by means of treatment with anti-IgE and the 
IgE-suppressed rats were more vulnerable to major infection with Trichinella (Watanabe et al., 
2005). Although there has been a contrasting result previously reported that IgE antibodies were 
accountable for the protection against muscle larvae using IgE gene knockout mice with a BALB/c 
background (Watanabe et al., 2005). In rats, rapid expulsion from the intestine is considered to be 
IgE-mediated protection against Trichinella spp and the muscle larvae are expelled immediately 
from the intestine of immunized animals after oral infection. Rapid expulsion in rats is induced by 
IgE antibodies and CD4+OX22- T cells (Watanabe et al., 2005). The IgE antibody binds to 
Trichinella spp to prevent invasion (Watanabe et al., 2005). A selective suppression of IgE 
production was developed in rats by treatment with anti-IgE. The IgE suppressed rats were more 
susceptible to primary infection with Trichinella spp (Watanabe et al., 2005). 
2.2.3 Global epidemiology and economic impact of Trichinella spp infection 
 
The etiological agents of human trichinellosis exhibit essentially global distribution in domestic 
and wild animals, aside from Antarctica, where there is no documentation of the parasite (Pozio, 
2007). This global distribution of Trichinella and ranging cultural consuming habits signify the 
primary factors favouring human infections in industrialized and non-industrialized countries. 
Human trichinellosis has been documented in 55 (27.8%) nations around the globe (Pozio, 2007). 
In a number of these countries, however, trichinellosis impacts mainly the ethnic minorities and 
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tourists due to the fact that the native inhabitants do not consume raw meat or meat of some animal 
species (Pozio, 2007). Trichinella spp. have been documented in domestic animals (in general 
pigs) and in wildlife of 43 (21.9%) and 66 (33.3%) countries respectively and out of the 198 nations 
of the world, approximately 40 (20%) are small islands with distance from the major continents, 
or metropolis–states where Trichinella spp. cannot circulate among animals for lack of nearby 
fauna (Pozio, 2007). Nevertheless, concrete information on the incidence of Trichinella spp in 
domestic and/or wild animals is still limited in 92 countries (Pozio and Murrell, 2006). 
Trichinellosis not only is a public health hazard by affecting human patients but also represents an 
economic challenge in porcine animal production and food safety (Gottstein et al., 2009). 
Trichinellosis has been an important, though often unrecognized, disease for thousands of years 
(Bruschi and Murrell, 2002). Species of Trichniella responsible for the infection are widely 
distributed, including the Arctic, temperate lands, and the tropics, humans appear to be especially 
prone to developing clinical disease. Infection in wild animal is far more common than is generally 





Figure 4: World map showing the distribution areas of Trichinella spiralis, Trichinella nativa, 
Trichinella britovi, Trichinella pseudospiralis, Trichinella nelsoni, Trichinella papuae, and 
Trichinella zimbabwensis (Pozio et al., 2002). 
2.2.4 Diagnosis of Trichinella 
 
The early clinical diagnosis of trichinellosis is difficult because of the absence of pathognomonic 
signs and symptoms, however, epidemiological data are very vital in the diagnosis of Trichinella 
infection, since the acute phase of this infection is associated with facial oedema and myalgia 
which might lead to complication of and thromboembolic and encephalitis disease (Dupouy-Camet 
and Murrell, 2007). Also, the chronic phase of the disease is not usually easy to diagnose. 
However, a delay in diagnosis and treatment in turns favours the establishment of larvae in muscle 
tissue and the development of a collagen capsule for the encapsulated species, which leaves the 
larvae difficult to treat with current antihelminthics (Pozio et al., 2001; Gottstein et al., 2009). 
Diagnosis of trichinellosis is basically based on three main criteria; the clinical symptoms, the 
laboratory findings and epidemiological investigation (Kociecka, 2000). Detection of circulating 
antigens with the aid of immunoassay methods may also be valuable for Trichinella diagnosis 
during the period of the parenteral phase, when the standard serological test designed to detect 
certain antibodies have yet to become positive, despite the fact that detection of circulating antigen 
perhaps might be a valuable confirmatory test although circulating antigen is not detected in every 
patient and its detection is consequently of limited value to the clinician (Dupouy-Camet and 
Murrell, 2007). Several studies have proven that eosinophilia is correlated with the degree of 
myalgia and is drastically higher in people with neurological problems, apart from moderately 
elevated white blood cell counts. Eosinophilia appears early prior to the development of clinical 
symptoms and signs, between the second and the fifth week of illness in different degrees, 
practically in each case of trichinellosis with only few exceptions (Gottstein et al., 2009). During 
the acute stage of infection, a tremendous decrease in eosinophil levels in patients with severe 
trichinellosis will also be viewed to be a predictor for a severe outcome. The mechanism 
underlying this decrease has not been absolutely understood, though it could be related to 
modifications in the levels of certain cytokines and to the massive exit of eosinophils from the 
vascular system, leading to huge tissue infiltrates (Dupouy-Camet and Murrell, 2007).  
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More so, trichinellosis cannot be exempted if this antibody class is not available, hence, IgE is not 
considered to show diagnostic relevance for routine diagnosis and again, IgA and IgM exhibit no 
advantage to conventional IgG detection (Noeckler et al., 2001). Furthermore, IgG antibodies can 
probably be verified between 12 to 60 days after infection, the time factor of seroconversion is 
dependent on a number of factors such as the number of ingested larvae, the Trichinella species 
involved, and the individual immune response (Gottstein et al., 2009). Out of conventional sero-
diagnostic methods, ELISA is essentially the most commonly used method for the detection of 
Trichinella infection in humans and the validation procedure of an ELISA to detect anti-
Trichinella IgG in human sera has revealed a large number of cross-reactions with sera from 
persons affected by other diseases, most often if these persons originate from developing countries 
where a high number of parasitic diseases occur (Gómez-Morales et al., 2008). The direct detection 
of muscle-stage larvae centered upon appropriate examination of muscle biopsies etiologically 
proves the diagnosis (Gottstein et al., 2009).   
2.2.5 Control and treatment of Trichinella infection 
 
As a result of the predominantly zoonotic importance of infection, most developed countries have 
focused on the prevention and elimination of Trichinella from the food chain (Gottstein et al., 
2009). Also, there are areas of uncertainty in the management of human trichinellosis because 
there have been very few perspective, controlled clinical trials of treatment for this infection 
(Dupouy-Camet and Murrell, 2007). Nevertheless, on an empiric basis, most specialists endorse 
the use of anthelminthics and corticosteroids (Gottstein et al., 2009). Anthelmintics used for the 
treatment of trichinellosis comprise primarily of albendazole (Zentel; Smith-Kline Beecham) and 
mebendazole (Vermox; Janssen Pharmaceutica, Beerse, Belgium) (Dupouy-Camet and Murrell, 
2007). Albendazole has the advantage that most patients reach requested plasma levels and for this 
reason do not require monitoring, meanwhile mebendazole plasma levels can fluctuate 
considerably among different patients and would require individual monitoring and dosing (Kadry 
et al., 2005). The application of anthelmintics at the stage of intestinal invasion aims particularly 
at the removal of intestinal forms of Trichinella spp. from the lumen of the gastrointestinal tract 
and such treatment is of primary significance for an early and effective therapy, mainly within the 
first three days following the infection (Kociecka, 2000).  If applied, such remedy prevents future 
muscular invasion and the spread of disease, moreso, in many instances; this option cannot be 
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acquired anymore (Gottstein et al., 2009). The sequel of anthelmintic therapy on the path of a more 
advanced stage of the infection, on lethality, and on already encysted larvae is obscured and poorly 
elucidated till present (Gottstein et al., 2009).  
Despite therapy, lethality in instances with excessive disease intensity was up to 5%, but in milder 
cases, prognosis is excellent, and most patients show a disappearance of symptoms within 2 to 6 
months whilst from time to time, chronic myalgia and rheumatalgia will persist (Gottstein et al., 
2009). Basically, the effectiveness of chemotherapy using albendazole or mebendazole is 
dependent on the time of administration and early application produce excellent result, although 
no sound case control efficacy studies have been conducted to date (Gottstein et al., 2009). 
Nevertheless, anthelmintics may not be usefull against long-term sequelae and chronic 
trichinellosis and an attempt to increase the bioavailability of anthelmintics have been successfully 
accepted in a mouse model by adding 2-hydroxypropyl-cyclodextrin (Casulli et al., 2006). 
Cymetidine has produced similar results on human cystic echinococcosis, although, experience is 
lacking for human trichinellosis (Gottstein et al., 2009). 
2.2.6 Co-infection of malaria and helminths  
 
Parasites are more often studied taking into consideration each parasite separately, more so, field 
experience has shown that infections with the aid of two or more parasite species at the same time 
frequently occur and this could have impact on the pathogenesis of each infection (Ademola and 
Odeniran, 2016). Although parasite host interactions could occur depending on the mechanisms 
by which, co-infections cause either more damage on the host than the combined effect outcome 
of the infectious agents, or less damage than the combined effect outcome of the infectious agents 
(Alizon and van Baalen, 2008). The interaction of the parasites which may have an impact on the 
epidemiology of co-infecting parasites could consequently influence the host wellbeing (Ezenwa 
and Jolles, 2011). Co-infections with malaria are usually complex and increase the severity of 
parasitic infection (Brooker et al., 2006a). Multiple parasitic infections are prevalent in tropical 
region (Ademola and Odeniran, 2016). Recent studies in vertebrates have shown that interactions 
between co-infecting parasites can be pronounced and have relevant consequences for disease 





Figure 5: World map showing the geographic distribution of malaria co-infection with helminths 
in humans (Salgame et al., 2013). 
2.2.7 The effect of helminths-malaria co-infection 
 
 Malaria and helminthiasis are the two types of the most prevalent of human infection in the 
developing world which overlap extensively in their epidemiological distributions and frequently 
co-infect the same individuals (Mazigo et al., 2010). The question of whether and how these two 
types of parasites might interact within co-infected hosts has attracted much curiosity and 
controversy (Knowles, 2011). Co- infecting parasites could interact both positively (facilitation) 
or negatively (competition) through a range of mechanisms including resource competition, 
immune-mediated interactions and direct interference (Knowles, 2011). Thus far, studies of 
helminth-malaria co-infection have focused mainly on immune-mediated mechanisms, without 
much doubt as a result of the known immunomodulatory effects of helminths (Grainger et al., 
2010). For this reason, it has been suggested that by polarizing immune responses towards Th2-
type effector mechanisms, helminths will reduce the pro-inflammatory Th1-type mechanisms 
needed to kill malaria parasites (Wammes et al., 2010). Secondly, helminths mostly elicit potent 
regulatory T cell (Treg) responses, which suppress all types of cellular effector mechanisms 
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including those against malaria parasites (Wammes et al., 2010). Several epidemiological studies 
have now sought evidence for effects of helminth co-infection on human malaria, with variable 
results, whilst some report high risk of clinical malaria in helminth co-infected individuals 
(Roussilhon et al., 2010), others find no effect or even suggest a protective effect (Knowles, 2011). 
Thus, firm conclusions about helminth-malaria interactions in humans and the likely effect of 


























 Chemicals were sourced as indicated: 
Giemsa stain (Sigma-Aldrich Chemical Company, Missouri, St Louis, USA); calcium chloride 
(CaCl2), potassium hydroxide (KOH), sodium sulphate (Na2SO4), sodium hydroxide (NaOH), 
Hydrochloric acid (Hcl). 
3.2 Ethical consideration 
  
Experimental protocols and procedures of the study were reviewed and approved by the Animals 
Ethics Committee of the University of KwaZulu-Natal (UKZN) (AREC/018/016 PD) in 
accordance with the South African national guidelines on animal care, handling and use for 
biomedical research. 
3.3 Study Animals 
 
Male Sprague-Dawley rats with body weight ranging from 90g-150g were used for the experiment. 
Animals were bred and housed in the Biomedical Resource Unit (BRU) of the University of 
KwaZulu-Natal, Westville campus and were maintained under standard laboratory conditions of 
constant temperature (22±2 °C), and CO2 content of <5000 p.p.m., relative humidity of 55±5%, 
and illumination (12 h light/dark cycles) with free access to feed (sterilized rodent pellets chow 
from Meadows, Pietermaritzburg, South Africa) and clean water.  
 
3.4 Experimental design 
 
Rats were randomly selected into four groups of 4 animals as follows; control group (C); malaria 

























Figure 6: Diagram showing experimental design 
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For each group, animals were randomly selected into groups of six animals per cage (n=6 in each 
group) with free access to clean water and heat sterilized rodent pellets ad libitum (Meadows, 
Pietermaritzburg, South Africa). The rats were maintained on a 12 h dark/light cycle and 
temperature (22±2 °C). Cage bedding was changed every second day to ensure a clean and stable 
environment. Terminal studies were done on 6 animals from each group on day 0, 7, 14, 21, 28, 
35 and 42 days and whole blood, sera and plasma collection and whole carcasses were digested 
for the Trichinella-infected groups on day 42. The serum and plasma samples were stored in a Bio 
Ultra freezer (Snijers Scientific, Tilburg, Netherlands) at -80 °C until assayed.  
3.5 Trichinella induction 
 
Forty-two (42) male Sprague-Dawley rats with body weight ranging from 90g-150g were used for 
the Trichinella group. The animals were housed at the Biomedical Resource Unit (BRU), 
University of KwaZulu-Natal. Animals were randomly selected into groups of six animals (n=6 in 
each group) with free access to clean water and standard heat sterilized rodent pellets ad libitum 
(Meadows, Pietermaritzburg, South Africa). The rats were maintained on a 12 h dark/light cycle 
and temperature (22±2 °C). Cage bedding was changed every second day to ensure a clean and 
stable environment. T. zimbabwensis infection was induced using a crocodile-derived T. 
zimbabwensis (ISS1209) parasite strain. The strain was maintained by a standardized serial 
infection of male Sprague-Dawley rats stock (150-250g). Muscle larvae were obtained from 
infected stock rats whole carcasses digested at 42 days post infection (dpi) following the method 
as previously described by (Pozio et al., 2002). The experimental animals were infected on day 0 
with T. zimbabwensis larvae by oral gavage at a dose of 500 muscle larvae (ML) per animal using 
an 18 G curved oral dosing needle. Recovery of adult worms from the intestines was achieved 
using a modification of the protocol by (Mukaratirwa et al., 2003). The small intestines were 
immersed in 0.85% saline solution, split open longitudinally with scissors and washed with H2O 
under 212μm sieve. After washing, the intestinal tissues were further incubated for 12hr at 37 ºC 
and then re-washed under a 212 μm. The washings were viewed under dissecting microscope at 
20 x objective for adult worm counts; whereas larvae in muscles were recovered using the modified 
artificial digestion protocol as described by (Pozio et al., 2002). Terminal studies were done on 0, 
7, 14, 21, 28, 35 and 42 days post infection. 
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3.6 Malaria induction  
  
Malaria was induced in forty-two (42) male Sprague-Dawley rats with body weight ranging from 
90g-150g. The animals were housed at the Biomedical Resource Unit (BRU), University of 
KwaZulu-Natal. Animals were randomly selected into groups of six animals per cage (n=6 in each 
group) with free access to clean water and standard heat sterilized rodent pellets ad libitum 
(Meadows, Pietermaritzburg, South Africa). The rats were maintained on a 12 h dark/light cycle 
and temperature (22±2 °C). Cage bedding was changed every second day to ensure a clean and 
stable environment. The rodent-susceptible P. berghei ANKA parasite was sourced from 
University of Cape Town, South Africa. Malaria induction was confirmed by microscopic 
examination of Giemsa stained thin blood smears from the rat tail (Andrews et al., 2006). The 
experimental animals were infected on day 28 by a single intra-peritoneal injection of P. berghei 
(105 parasitised RBC). Daily malaria parasite density was measured in P berghei-infected animals 
throughout the remaining 14 day experimental period using thin blood films stained by Giemsa 
method. The slides were observed using an Olympus microscope (Olympus cooperation, Tokyo, 
Japan) with a x50–x100 oil immersion objective and percentage parasitaemia was determined 
3.6.1 Plasmodium berghei ANKA and Trichinella zimbabwensis co-infection induction 
 
Forty-two (42) male Sprague-Dawley rats with body weight ranging from 90g-150g were used for 
the co-infection group. The animals were housed and maintained as previously described in the 
other groups. The experimental animals were infected on day 0 with T. zimbabwensis larvae by 
oral gavage at a dose of 500 muscle larvae (ML) per animal using an 18 G curved oral dosing 
needle and the same animals were co-infected with P. berghei on day 28 post-T. zimbabwensis 
infection by a single intra-peritoneal injection of P. berghei (105 parasitised RBC) (Gumede et al., 
2003). P, berghei parasitaemia was measured daily throughout the remaining 14 days using thin 
blood films stained by Giemsa method. Recovery of adult T. zimbabwensis worms from the 
intestines was achieved using a modification of the protocol by (Mukaratirwa et al., 2003). Larvae 
in muscles were recovered using the modified artificial digestion protocol as described by (Pozio 
et al., 2002). Terminal studies were done on 0, 7, 14, 21, 28, 35 and 42days post infection. 
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3.6.2 Plasmodium berghei parasitaemia measurement 
 
Parasitaemia was determined in two groups, the malaria infected (M) and co-infected (MT), after 
infecting the experimental animals with P. berghei on day 28. Daily P. berghei parasitaemia was 
measured in the two groups throughout the remaining 14day experimental period. Thin blood films 
stained were examined. Briefly, a small incision in the tip of the rat tail was made followed by 
placing a small drop of blood on a microscope slide. This was smoothly and uniformly smeared 
using a second microscope slide. The blood film on the slide was subsequently dried in a stream 
of warm air, fixed in methanol for 30 s and then stained with Giemsa stain for 30-45 min, thereafter 
the stained slide was washed gently with buffer (7.4), the blood film was air dried at room 
temperature and observed using an Olympus microscope (Olympus cooperation, Tokyo, Japan) 
with a x50–x100 oil immersion objective. Extreme caution was taken to distinguish parasites from 
inclusions in RBC such as Howell-Jolly bodies, platelets on top of RBC, or from precipitated stain. 
Parasitaemia count of 5 microscope fields was followed by calculation of the percentage of 
infected RBCs. The parasite determination was the same for the malaria infected (M) and co-
infected (MT) groups. 
% Parasitaemia =  
Total RBCs infected with 𝑃. 𝑏𝑒𝑟𝑔ℎ𝑒𝑖
Total RBC counted (infected + non − infected)
 × 100 
 
3.6.3 Terminal studies 
 
On days 0, 7, 14, 21, 28, 35 and 42 post-infection, six animals were sacrificed from each group. 
The sacrifice procedure was performed by isoform inhalation in an anaesthetic chamber for 3 
minutes. Blood was collected from the rats on the days of sacrifice by cardiac puncture into 1 ml 
blood tubes containing clotting activator gel (dvac gel and clot activator tubes). The blood was 
subject to centrifugation using a Thermo scientific Heraeus Labofuge 200 microprocessor 
controlled table top centrifuge at 132 xg for 10 - 15 minutes at 4 °C. Following centrifugation, 
serum was collected into Eppendorf micro-centrifuge tubes. The plasma samples were stored in 
Bio Ultra freezer (Snijers Scientific, Tilburg, Netherlands) at -80 °C until assayed. Cytokines 
concentrations were measured using ELISA. Recovery of adult worms from the intestines was 
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done using a modification of the protocol described by Mukaratirwa et al., (2003) and muscle 
larvae were recovered using the modified artificial digestion protocol as described by Pozio et al., 
(2002). 
3.6.4 Haematological profile measurement 
 
Blood sample for haematological analysis was collected from each rat through cardiac puncture. 
The blood samples were collected into sample bottles containing ethylene diamine–tetra-acetic 
acid (EDTA). The parameters analyzed included white blood cell count (WBC), red blood cell 
count (RBC), haemoglobin (HGB), haematocrit (HCT), eosinophils (EO), neutrophils (NE), 
lymphocytes (LY), monocytes (MO) and basophils (BA). These parameters were measured using 
A C.T 5diff Beckman coulter counter (BCC) made in USA.  
3.6.5 Cytokines measurement 
 
To determine the levels of cytokines in sera, Procartalplex Mix&Match Rat 7-plex was used to 
measure Tumor necrosis factor-alpha (TNF-α) and Interleukin-10 (IL-10) levels in serum 
according to manufacturer’s instructions. Different antigen standard set vials were centrifuged at 
2000 x g for 10 sec. 50 µl of sample type specific buffer was added into the vial and a Universal 
Assay Buffer(1x) was used to reconstitute the standard. The vial was vortex gently for 10 seconds 
and centrifuged at 2000 x g for another 10 seconds to collect the content at the bottom of the vials. 
The vial was incubated on ice for 10mins to ensure complete reconstitution. Each content in the 
vial was pooled into one vial and filled up with type specific buffer to a total volume of 250 µl. 4-
fold serial dilution of the reconstitution standard was prepared using the PCR 8 tubes and was 
labeled as Std1, Std2, Std3, Std4, Std5, Std6 and Std7 respectively.  
The Antibody Magnetic Beads were vortex for 30 sec, and 50 μL of the Antibody Magnetic Beads 
were added to each well. A Procarta 96-Well Flat Bottom Plate was inserted into the Hand-Held 
Magnetic Plate Washer so that the A1 location of the 96-Well Plate matches up with the A1 on the 
washer, the 96-Well Plate was locked in place by pushing the 2 securing tabs, located on each end 
of the washer, towards the 96-Well Plate until they overlap the skirt of the 96-Well Plate. The 
Antibody Magnetic Beads were allowed to accumulate on the bottom of each well for 2 min, and 
the liquid was removed in the wells by quickly inverting the Hand-Held Magnetic Plate Washer 
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and 96-Well Plate assembly over a sink, the inverted assembly was blot into several layers of paper 
towels to remove any residual solution, and 150 μL of 1X Wash Buffer was added into each well. 
The Antibody Magnetic Beads was allowed to accumulate on the bottom of each well for 30 sec, 
and the wash buffer in the wells was removed by quickly inverting the Hand-Held Magnetic 
Washer and 96-Well Plate assembly over a sink. 25 μL of Universal Assay Buffer was added into 
each well, 25 μL of standards were also added into dedicated wells and 25 μL of Universal Assay 
Buffer to the blank wells. The 96-Well Plate was sealed using a Plate Seal provided. Afterwards, 
the 96-Well Plate was removed from the Hand-Held Magnetic Plate Washer and covered with the 
black microplate lid that was provided in the kit in order to protect it from light. The 96-Well Plate 
was shaken at 500 rpm for 120 min at room temperature and the plate was transferred to 4 °C and 
store on a level surface. After incubation, the 96-Well Plate was removed from 4 °C and shaken 
again for 30 min at room temperature.  
The plate was washed for a total of three washes following the previous method as described 
above. 25 μL of Detection Antibodies Mix (1x) was added into each well and sealed the 96-Well 
Plate with a new Plate seal. The 96-Well Plate was removed from the Hand-Held Magnetic Plate 
Washer, covered with the black microplate lid provided in the kit and shake at 500 rpm for 30 min 
at room temperature. The plate was washed for a total of three washes following the previous 
method as described above and 50 μL of SA-PE solution was added into each well, the 96-Well 
Plate was again sealed with a new Plate seal. The 96-Well Plate was removed from the Hand-Held 
Magnetic Plate Washer and the plate was covered with the black mic roplate lid provided in the 
kit and shaken at 500 rpm for 30 min at room temperature. The plate was washed again for a total 
of three washes following the previous method as described above and 120 μL of Reading Buffer 
was added into each well. The 96-Well Plate was sealed with a new Plate Seal, the 96-Well Plate 
was removed from the Hand-Held Magnetic Plate Washer, covered with the black microplate lid 
provided in the kit and shakes at 500 rpm for 5 min at room temperature. The plate seal was 





3.6.6 Statistical analysis 
 
All data were expressed as means ± standard error of means (SEM), the data was analysed using 
a two-way analysis of variance (ANOVA) followed by Turkey-Kramer multiple comparison test 
to establish statistical comparison between various groups control, malaria, Trichinella, and co-
infection groups. Levels of significance were determined by Bonferroni post-hoc test analyses.  
All data were expressed as mean ± standard error of mean (SEM). Two-way analysis of variance 
(ANOVA) with accompanying Tukey’s post-hoc analysis for parametric data was used to compare 
mean values of adult worms and mean values of muscle larvae using Graph pad PRISM version 
5.04 for windows (Graphpad software, San Diego, California, USA) and the differences between 




















4.0 CHAPTER 4: RESULTS 
 
4.1 Percentage parasitaemia after P. berghei infection  
 
All animals did not make it safely to their terminal stage, two animals died in the malaria infected 
group, it could be due to high parasitaemia. The malaria mean parasitaemia and standard error 
mean was determined in the present study, on day 2 after P. berghei infection, the P. berghei (MI) 
group developed mean parasitaemia of 20.88% ± 1.47% while the co-infected with P. berghei and 
T. zimbabwensis (CI) developed a mean parasitaemia of 23.02% ± 0.92%. On day 3, the P. berghei 
(MI) group means parasitaemia increased to 23.70% ± 2.55% (p < 0.01) and 41.25% ± 1.61% in 
the P. berghei and T. zimbabwensis (CI). On day 4, the mean parasitaemia increased to 28.63% ± 
4.22% (p < 0.001) and 50.20% ± 5.38% respectively. The P. berghei (MI) group reached the peak 
at day 6 with 66.77% ± 4.63% while the P. berghei and T. zimbabwensis (CI) reached its peak on 
day 7 with 69.17% ± 3.80%. There was a gradual decrease of malaria mean parasitaemia in both 
P. berghei only (MI) and co-infected with P. berghei and T. zimbabwensis (CI) till day 14. 
However, infection of rats with P. berghei and T. zimbabwensis (CI) resulted in increased 
parasitaemia compared to P. berghei mono-infected rats. The effects of P. berghei and T. 
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 Figure 7: Percentage parasitaemia in male Sprague-Dawley rats infected with Plasmodium 
berghei only (MI) and co-infected with P. berghei and T. zimbabwensis (CI). Day 0 represents the 
day of P. berghei induction and 28 days post-infection with T. zimbabwensis when Trichinella 
larvae are now in the rat muscle). Values are presented as means and vertical bars indicate SEM 








4.2 Trichinella zimbabwensis parasite establishment 
 
The adult worms (AW) of T. zimbabwensis in the intestine of male Sprague-Dawley rats were 
recovered in both the T. zimbabwensis group (MI) and the P. berghei and T. zimbabwensis group 
(CI) from day 7 to day 14 post infection (Fig. 8), the adult worms in the T. zimbabwensis group 
(MI) were more on day 7 with a mean of 18.50% ± 8.06% while the co-infected with P. berghei 
and T. zimbabwensis (CI) developed a mean of 15.00% ± 6.44%. There was a decrease on day 14 
in both groups, the mean adult worm (AW) of T. zimbabwensis decreased to 3.00% ± 0.0% and 
1.00% ± 0.0% respectively, at day 21 post infection, there was no adult worm recovered in the 
intestine in both groups. Muscle larvae were recovered from the muscle on the day 28, 35 and 42 
post infection in both groups. On day 28, the T. zimbabwensis group (MI) had a mean of 41.50% 
± 22.0%. larvae per gram (lpg) of muscle while the P. berghei and T. zimbabwensis group (CI) 
had a mean of 48.70% ± 23.14%. On day 35, the mean muscle larvae (ML) of T. zimbabwensis 
increased to 48.60% ± 7.49% in the T. zimbabwensis group (MI) and a slide decrease of 46.57% 
± 11.2% in the P. berghei and T. zimbabwensis group (CI). On day 42, the T. zimbabwensis group 
(MI) increased exponentially with a mean of 97.37% ± 20.6% compare to the P. berghei and T. 
zimbabwensis group (CI) 71.63% ± 17.11%. The effects of P. berghei and T. zimbabwensis co-
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Figure 8: Mean number of intestinal adult worms (AW) and muscle larvae counts (ML) per gram 
of muscle (lpg) recovered from rats infected with Trichinella zimbabwensis only (MI) and the 
group co-infected with Plasmodium berghei (CI) on day 28 post-infection with T. zimbabwensis. 










Haematological changes were observed in different groups of the experiment, control (C), 
Plasmodium berghei (MI) group, Trichinella zimbabwensis (MI) and P. berghei and T. 
zimbabwensis (CI) group. In this study, there was a significant (p < 0.001) decrease in the RBC in 
rats infected with T. zimbabwensis (MI) and P. berghei and T. zimbabwensis (CI) group on day 7, 
a decrease was also observed in the P. berghei (MI) group on day 7 p.i. although it was not 
significant, a significant (p < 0.01) decrease in the P. berghei and T. zimbabwensis (CI) group was 
observed on day 14 p.i. respectively (Fig. 9). However, there was no significant difference in the 
WBC count among the P. berghei (MI), T. zimbabwensis (MI) and the co-infection (CI) group but 
a trend increase was observed in all the groups as compare to the control group (Fig. 10). Regarding 
haemoglobin counts, significantly (p < 0.05) high count was only observed on day 14 p.i in the T. 
zimbabwensis (MI) group (Fig. 11). A significant (p < 0.05) reduction (30.0% ± 4.0%) in 
haemotocrit counts was observed for P. berghei (MI), also a significant (p < 0.001) reduction 
(7.31.0% ± 4.2%) in T. zimbabwensis (MI), and a significant (p < 0.001) reduction (4.15% ± 1.5%) 
in P. berghei and T. zimbabwensis (CI) group was observed on day 7 p.i. (Fig. 12). A significant 
(p < 0.001) neutropaenia increase (22.88% ± 2.31%) was observed on day 7 p.i. in the P. berghei 
and T. zimbabwensis (CI) group compare to the control group (8.21% ± 1.31%), while the P. 
berghei (MI), Trichinella zimbabwensis (MI) and P. berghei and T. zimbabwensis (CI) groups 
presented almost normal neutrophil counts on Day 14 p.i. (Fig. 13). A significant (p < 0.001) 
reduction (38.12% ± 4.5%) in lymphocyte counts was observed for T. zimbabwensis (MI) group 
and a significant (p < 0.01) reduction (51.93% ± 7.31%) in the P. berghei and T. zimbabwensis 
(CI) group on day 7 p.i. compared to the P. berghei (MI), and control groups (Fig. 14). Significant 
(p < 0.001) monocytosis was observed in P. berghei (MI) group on day 7 and on day 14 p.i., 
although the Trichinella zimbabwensis (MI) and the P. berghei and T. zimbabwensis (CI) also 
showed gradual increase compare to the control group (Fig. 15). Also, rats infected with T. 
zimbabwensis (MI) and P. berghei and T. zimbabwensis (CI) showed significant (p < 0.001) 
increase of basophils on day 7 p.i compared with the uninfected (C), although there was a slight 






























Figure 9: Comparison of the effects of Plasmodium berghei and Trichinella zimbabwensis mono-
infection (MI) and co-infection (CI) on RBC concentration in male Sprague-Dawley rats. Day 0 
represents the day of P. berghei when Trichinella muscle larvae is now in the rat muscle at day 28 
post Trichinella infection. Values are presented as means and vertical bars indicate SEM (n=6 in 
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Figure 10: Comparison of the effects of Plasmodium berghei and Trichinella zimbabwensis mono-
infection (MI) and co-infection (CI) on WBC concentration in male Sprague-Dawley rats. Day 0 
represents the day of P. berghei when Trichinella muscle larvae is now in the rat muscle at day 28 
post Trichinella infection. Values are presented as means and vertical bars indicate SEM (n=6 in 
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Figure 11: Comparison of the effects of Plasmodium berghei and Trichinella zimbabwensis mono-
infection (MI) and co-infection (CI) on haemoglobin concentration in male Sprague-Dawley rats. 
Day 0 represents the day of P. berghei when Trichinella muscle larvae is now in the rat muscle at 
day 28 post Trichinella infection. Values are presented as means and vertical bars indicate SEM 






























Figure 12: Comparison of the effects of Plasmodium berghei and Trichinella zimbabwensis mono-
infection (MI) and co-infection (CI) on haematocrit concentration in male Sprague-Dawley rats. 
Day 0 represents the day of P. berghei when Trichinella muscle larvae is now in the rat muscle at 
day 28 post Trichinella infection. Values are presented as means and vertical bars indicate SEM 













CI (P. berghei and T. zimbabwensis)
***












Figure 13: Comparison of the effects of Plasmodium berghei and Trichinella zimbabwensis mono-
infection (MI) and co-infection (CI) on neutrophils concentration in male Sprague-Dawley rats. 
Day 0 represents the day of P. berghei when Trichinella muscle larvae is now in the rat muscle at 
day 28 post Trichinella infection. Values are presented as means and vertical bars indicate SEM 
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Figure 14: Comparison of the effects of Plasmodium berghei and Trichinella zimbabwensis mono-
infection (MI) and co-infection (CI) on lymphocytes concentration in male Sprague-Dawley rats. 
Day 0 represents the day of P. berghei when Trichinella muscle larvae is now in the rat muscle at 
day 28 post Trichinella infection. Values are presented as means and vertical bars indicate SEM 
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Figure 15: Comparison of the effects of Plasmodium berghei and Trichinella zimbabwensis mono-
infection (MI) and co-infection (CI) on monocytes concentration in male Sprague-Dawley rats. 
Day 0 represents the day of P. berghei when Trichinella muscle larvae is now in the rat muscle at 
day 28 post Trichinella infection. Values are presented as means and vertical bars indicate SEM 
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Figure 16: Comparison of the effects of Plasmodium berghei and Trichinella zimbabwensis mono-
infection (MI) and co-infection (CI) on basophils concentration in male Sprague-Dawley rats. Day 
0 represents the day of P. berghei when Trichinella muscle larvae is now in the rat muscle at day 
28 post Trichinella infection. Values are presented as means and vertical bars indicate SEM (n=6 







4.4 Cytokines levels 
 
TNF-α for the P. berghei (MI) group at day 7 post infection (535.6% ± 216.2%), was significantly 
different as compared to that of the control group (11.42% ± 4.06%). A decrease of (26.03% ± 
11.75%) was also observed in the T. zimbabwensis (MI) group, however, P. berghei and T. 
zimbabwensis (CI) group decreased to (8.93% ± 1.50%). At day 14 p.i., decrease of (10.64% ± 
1.68%), (8.16% ± 1.79%) and (6.74% ± 1.11%) was observed in all the groups P. berghei (MI), 
T. zimbabwensis (MI), and P. berghei and T. zimbabwensis (CI) group, although, these decrease 
was not statistically significant (P>0.05) (Fig. 17). At day 7 post infection, significant levels of 
Interleukin-10 (IL-10) concentrations was observed in the P. berghei (MI) group (p < 0.001) 
increase (3163% ± 14.8%) compare to the control (165.7% ± 27.27%), a slight increase of (169.1% 
± 22.7%) was also observed in the T. zimbabwensis (MI) group, while a decrease of (156.9% ± 
59.2%) was observed in the P. berghei and T. zimbabwensis (CI) group. At day 14 p.i., an increase 
of (322.8% ± 39.7%) and (192.4% ± 56.08%) was observed in the P. berghei (MI) group and P. 
berghei and T. zimbabwensis (CI) group respectively, while the T. zimbabwensis (MI) group 
decease to (145,6% ± 31.1%) compare to the control (165.7% ± 27.27%) (Fig.18). IL-4 and IL-6 
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Figure 17: Comparison of the effects of Plasmodium berghei and Trichinella zimbabwensis mono-
infection (MI) and co-infection (CI) on TNF-α concentration in male Sprague-Dawley rats. Day 0 
represents the day of P. berghei when Trichinella muscle larvae is now in the rat muscle at day 28 
post Trichinella infection. Values are presented as means and vertical bars indicate SEM (n=6 in 
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Figure 18: Comparison of the effects of Plasmodium berghei and Trichinella zimbabwensis mono-
infection (MI) and co-infection (CI) on IL-10 concentration in male Sprague-Dawley rats. Day 0 
represents the day of P. berghei when Trichinella muscle larvae is now in the rat muscle at day 28 
post Trichinella infection. Values are presented as means and vertical bars indicate SEM (n=6 in 







5.0 CHAPTER 5: DISCUSSION 
 
Helminths infections and malaria are common among populations in developing countries 
indicating that there may be interactions between parasites, as suggested by previous studies 
(Ademola and Odeniran, 2016). Over the years, most research has concentrated on single species 
parasite infections, recently there has been a resurgence of interest in contextual predictors of co-
infcetions and an increased recognition of the global burden of disease attributable to neglected 
tropical diseases (NTDs). To the best of our knowledge, no studies have been carried out on the 
cytokine profile in Sprague-Dawley rats experimentally infected with T.  zimbabwensis and P. 
berghei ANKA.  
In the present study, we observed that P. berghei and T. zimbabwensis (CI) group showed rapid P. 
berghei development and increased parasitaemia than rats in the P. berghei (MI) group. A 
significant parasitaemia reduction was observed on day 3 and 4 in the P. berghei mono-infected 
group, and this demonstrates that depending on the existing immune interaction between a given 
host and malaria parasites, addition of a helminth co-infection may have contradicting effects on 
severity of malarial disease. This observation is in accordance with previous work (Bucher et al., 
2011; Ademola and Odeniran, 2016) which also reported high parasitaemia during the early stages 
of malaria in chronic S. mansoni and P. berghei co-infected mice. The increase observed in 
parasitaemia in the co-infection group of rats may delay parasite clearance even after treatment 
(Legesse et al., 2004). The understanding of the mechanisms by which parasite interactions occur 
is still very limited. Antagonistic responses could aggravate the diseases pathologic effect of the 
infections, whereas, synergistic responses could decrease the diseases (Briand et al., 2005; 
Ademola and Odeniran, 2016; Babamale et al., 2017). In this present study, the antagonistic 
responses of the host to the parasite might have aggravated the infection in the P. berghei and T. 
zimbabwensis co-infected rats.  
In resolving rodent malaria infections, blood parasitaemia is essentially controlled by an early and 
robust pro-inflammatory response and is kept under control by the anti-inflammatory cytokines 
IL-10 and TGF- β (Li et al., 2003). Increased inflammatory cytokines or decreased levels of anti-
inflammatory cytokines have been found in severe malaria (Hunt and Grau, 2003; Sanni et al., 
2004; Mitchell et al., 2005). The Trichinella dose and stage of infection could be one of key factors 
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influencing the size and direction of effect on malaria parasites in this study. There is also limited 
evidence from humans that dose effects may be very crucial in determining helminth-Plasmodium 
interactions (Nacher et al., 2002).  
The results of the present study show that T. zimbabwensis adult worms persisted in the mono-
infected and co-infected group in the small intestines from day 7 up to day 14 post infection. Our 
findings show that Th1-type cytokine and TNF-α were markedly produced as early as day 7 pi, 
which is not the case with T. spiralis infection (Fabre et al., 2009). No adult worms were recovered 
in both groups on day 21 post infection. Trichinella zimbabwensis muscle larvae (ML) were 
recovered from day 28 up to day 42 p.i. with an exponential increase in the Trichinella mono-
infected group. This implies that the bulk of the larval migrations are mainly after day 21 p.i. 
Studies regarding the immune evasion mechanisms of Trichinella infection have been previously 
reported and in particular, IL-10 is reported to act as an inflammation regulator in cases of 
intestinal and muscle trichinellosis in mice (Park et al., 2011). Increased level of TNF-α cytokine 
was observed at day 7 p.i, which suggest that a protective immune response is established against 
T. zimbabwensis AW and NBL, which is geared towards AW expulsion, abrogation of 
inflammation caused by NBL or parasite killing (Harnett and Harnett, 2010) and eventual tissue 
healing (Maizels et al., 2009; Onkoba et al., 2015b). However, it is an established fact that IL-10 
alone does not have effect on parasite survival, but in combination with TGF-β, parasite death 
occurs (Beiting et al., 2007). Helminth infections induce strong Th2 as well as regulatory T cell 
responses, and both of which are capable of dampening inflammatory responses (Maizels and 
Yazdanbakhsh, 2003; Maizels, 2009). 
Significant decrease in the RBC in rats infected with T. zimbabwensis (MI) and P. berghei and T. 
zimbabwensis (CI) was observed on day 7 p.i, which is an indication of anaemia. This could be as 
a result of high destruction of erythrocytes and these results are in agreement with those reported 
earlier (Holy et al., 2015; Kanu et al., 2016). Blood parameters can be used as pathological and 
physiological indicators of animal health and one of the common pathological features observed 
in human as well as the experimental T. zimbabwensis mono-infected and co-infection groups is 
the loss of red blood cell resulting in anaemia and the degree of anaemia is an indicator of the 
disease severity (Ademola and Odeniran, 2016). Anaemia during trichinellosis might be due to 
either loss of RBC (Stijlemans et al., 2008). Anaemia is also one of the most common 
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complications in malaria infection in young children and pregnant women in hyperendemic areas 
(Ladhani et al., 2002; Maina et al., 2010). Decreased production of RBCs associated with malaria 
infection may also lead to development of anaemia through varied mechanisms (Fendel et al., 
2010).  
There was no significant difference in WBC count among the P. berghei and T. zimbabwensis 
mono-infection and co-infection groups. These results are comparable with other studies (Adedapo 
et al., 2007; Maina et al., 2010), which reported no significant difference in WBC between the 
Plasmodium-infected and non-infected groups. In contrast, other studies have demonstrated 
leukocytosis (Celik et al., 2009). Leukocytosis may be as a result of benign conditions such as 
inflammation-tissue necrosis, stress, hemolytic anaemia and infections (Kanu et al., 2016). The 
present study demonstrates a significant low haemoglobin levels in the P. berghei (MI) group at 
day 7 and 14, and an increase in the T. zimbabwensis and co-infection groups. The decrease in the 
haemoglobin level is mostly associated with Plasmodium infection, and is caused by the 
destruction of infected RBCs and a decrease in cell production (Gansane et al., 2013). In sub-
Saharan Africa, other factors which contribute to decreased haemoglobin levels in children include 
poor nutritional status, soil-transmitted helminths or other intestinal parasite infections and poor 
access to health care (Gansane et al., 2013). A significant decrease of haemotocrit was observed 
in the P. berghei (MI) group, T. zimbabwensis (MI) and P. berghei and T. zimbabwensis (CI) group 
as compared to the control group. This reduction in P. berghei is consistent with previous studies 
that have reported Plasmodium-induced anaemia (Menendez et al., 2000). 
An increase in neutrophils at day 7 in the P. berghei and T. zimbabwensis (CI) group and a decrease 
in the co-infection group on day 14 was observed. The neutrophils are responsible for phagocytosis 
of pathogenic microorganisms and similarly, marked depression of precursor cells and marked 
phagocytosis of neutrophil precursor cell within the bone marrow and spleen may have been 
responsible for the severe drop in neutrophil number in the co-infection group on day 14 (Ademola 
and Odeniran, 2016). Cytokines and interleukins that are released after lysis of neutrophils plays 
crucial role in bone marrow stimulation to release neutrophils so that the production of neutrophils 
is increased (Maslachah and Sugihartuti, 2017). Neutrophils function as the first line of defense to 
eradicate P. berghei by phagocytizing parasites. This implies that infections of longer duration will 
elevate the percentage of parasitemia in the rats so that the increased numbers of parasites will 
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suppress the immune system (immunosupression), causing the immune system to become 
inadequate and unable to respond properly (Maslachah and Sugihartuti, 2017). High parasitemia 
rates will improve the mechanism of parasite invasion and suppress the host immune system 
(Onwuamah et al., 2010). Neutrophils play a crucial role in the immune response by modulating 
both cellular and humoral immunity through the synthesis and release of immunoregulatory 
cytokines (Maslachah and Sugihartuti, 2017). 
Lynphocytes decreased at day 7 in the T. zimbabwensis mono-infection, co-infection groups and a 
decrease in the P. berghei group, at day 14 a gradual decrease was also observered in the P. berghei 
group. The decrease signifies lymphopaenia and suggests that T. zimbabwensis caused marked 
antigenic stimulation which leads to the acceleration and transformation of lymphocytes to plasma 
cells and transferred lymphocytes resulting to lymphopaenia. The decrease in lymphocytes counts 
associated with malaria observed in the study may be redistribution of lymphocytes with 
sequestration in the spleen (Erhart et al., 2004). Lymphocytes are involved in humoral and cellular 
immunity which is activated by T helper (Th) lymphocytes, which are a subset of T cells needed 
in the induction of immune responses against an invasion of foreign antigens (Maslachah and 
Sugihartuti, 2017). Moreover, an extremely severe course of trichinellosis may be accompanied 
by lymphopenia which is a manifestation of immunosuppression (Mukaratirwa et al., 2008). 
However, increase in the number of monocytes was observed in all the groups at day 7 compared 
to the control. These increases could be due to high demand for removal of particulate matter 
arising from severe pathology. The observation of increased monocytes counts in P. berghei, T. 
zimbabwensis mono-infection and co-infection groups from this study is in agreement with the 
earlier observations (Maina et al., 2010; Kotepui et al., 2014). Mononuclear cells are activated by 
Plasmodium during malarial infection and these cells produce inflammatory cytokines, such as 
interleukin-6 (IL6) and tumor necrosis factor (TNF). These cytokines help in the stimulation of 
the hepatic synthesis of acute phase inflammatory proteins, including CRP, which increase during 
malaria infection (Kotepui et al., 2014). Increased basophil was observed in P. berghei, T. 
zimbabwensis mono-infection and co-infection groups, the increase in basophils levels maybe as 
a result of hemolytic anaemia (Zainuddin, 2015). The increase in basophil count associated with 
malaria infection was in contrast with previous studies (Pelleau et al., 2012), which observed a 
decrease in the number of peripheral blood basophils that was related to the severity of symptoms. 




TNF-α for the P. berghei mono-infected group at day 7 post infection increased significantly. The 
increased TNF-α levels suggest that TNF-α may be involved in the pathogenesis of malaria (Sahu 
et al., 2016b). A decrease in the levels of TNF-α was observed in T. zimbabwensis (MI) group, 
which is in agreement with the previous study (Onkoba et al., 2015b; Onkoba et al., 2016). This 
may imply that the parasite may be immune-modulating host immune system to initiate Th2 
polarization that down-regulate production of pro-inflammatory cytokines (Harnett, 2014). 
Whereas, low levels of TNF-α and IFN-γ observed in the high transmission sites for malaria could 
be due to the reduction of T-cell subset (Ademolue et al., 2017). Previous studies have shown that 
prolonged stimulation of CD4+ T-cells with increased level of antigens mediate adaptive peripheral 
tolerance, which is characterized by unresponsiveness to further stimulation, with an evident 
decrease in the secretion of TNF-α, IFN-γ, IL-2, and IL-6 (Mueller, 2010; Xing and Hogquist, 
2012; Ademolue et al., 2017). The induction of a regulatory network of anti-inflammatory 
cytokines such as IL-10 and pro-inflammatory cytokine such as TNF-α might preclude pathology 
in the later stages of malaria infection. Schistosoma haematobium and P. falciparum co-infected 
patients had higher plasma levels of IFN-γ and similar levels of TNF-α, TGF-β and IL-10, 
compared to children infected with malaria only (Hartgers and Yazdanbakhsh, 2006). Increased 
levels of pro-inflammatory cytokines such as IFN-γ, IL-1, TNF-α and IFN-γ -induced protein (IP)-
10 (CXCL10) form part of an early host response to the parasite and these cytokines have also 
been associated with severe anaemia, hyperglycemia and cerebral malaria in P. falciparum 
infection (Armah et al., 2007; do Rosario and Langhorne, 2012). Increased level of IL-10 was 
observed in the P. berghei (MI) group in this study. High levels of IL-10 have also been associated 
with increased disease severity in humans, including cerebral malaria, anaemia and respiratory 
distress (Prakash et al., 2006; Ong’echa et al., 2008; Ayimba et al., 2011; do Rosario and 
Langhorne, 2012). Studies regarding the immune evasion mechanisms of Trichinella infection 
have been previously reported, in particular, IL-10 operates as an inflammation regulator in cases 
of intestinal and muscle trichinellosis in mice (Park et al., 2011). According to previous studies, it 
has been demonstrated that CD4+CD25+ T cells producing IL-10 play a vital role during 
Plasmodium infection, possibly controlling the pro-inflammatory cytokines IFN-γ and TNF (Riley 
et al., 2006; Hojo-Souza et al., 2017). However, according to recent findings, IL-10 has been 
described as the strongest predictor of disease in endemic regions (Sinha et al., 2010) and 
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considered as a biomarker for inflammatory placental malaria (Kabyemela et al., 2008). This is in 
agreement with our data showing that at the point of peak parasitemia, the pro-inflammatory 
response is down-regulated and a concomitant increase in IL-10 is detected in the P. berghei mono- 
infected group. This finding may represent an attempt to balance the pro-inflammatory response 
and to prevent immune-mediated pathology.  
IL-4 and IL-6 serum concentration were below the lowest standard of the assay protocol, these 
could be due to some other components of the assays such as the proprietary monoclonal antibody 
pairs that make them less sensitive. Another reason for not being able to detect IL-4 and IL-6 could 
be because of the presence of inhibitors that not only bind and inactivate the cytokines but also 
interfere with their detection. More importantly, there are inhibitors and antagonists in the plasma 
which often interfere with the immunoassays used to quantitate IL-4 and IL-6, this becomes very 
vital because the presence of these inhibitors or antagonists in the plasma may be used to document 














6.0 CONCLUSIONS AND RECOMMENDATIONS 
 
In conclusion, we observed that P. berghei and T. zimbabwensis (CI) group showed rapid 
development and increased parasitaemia than rats in the P. berghei (MI) group. Therefore, rats co-
infected with P. berghei and T. zimbabwensis may aggravate the course of disease in the host by 
increasing parasitaemia, but elevated IL-10 plays a crucial role in the suppression of hepatic 
pathology in the host. Data presented here demonstrate that an early stage intestinal nematode 
infection can enhance malaria-associated pathology without necessarily altering immune 
reactivity, and larval infections may also alter disease progression in different ways. Increased IL-
10 is essential in down-regulation of protective immunity against malaria parasites possibly due to 
its hematopoietic, immunoregulatory, and developmental properties. 
Limitations 
The main limitation of this study is that IL-4 and IL-6 did not produce result as concentrations 
were below the assay protocol. This could be due to some other components of the assays such as 
the proprietary monoclonal antibody pairs that make them less sensitive. The primary reason for 
not being able to detect IL-4 and IL-6 could also be due to the presence of inhibitors that not only 
bind and inactivate the cytokines but also interfere with their detection. 
Recommendations 
Future research studies are necessary to further investigate the impact of different Trichinella 
species on malaria infection, immunology, and pathology in order to understand the mechanism 
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Regression Type: Logistic - 5PL  
Std. Curve: FI = -24.4997 + (3917.24 + 24.4997) / ((1 + (Conc / 1370.96)^-0.72333))^1.49635 
 FitProb. = 0.4347, ResVar. = 0.6103 
 


















































Regression Type: Logistic - 5PL 
 
Std. Curve: FI = -8.98322 + (2683.92 + 8.98322) / ((1 + (Conc / 32578.4)^-12.0632))^0.1 
 
FitProb. = 0.0335, ResVar. = 4.5211 
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Regression Type: Logistic - 5PL 
 
Std. Curve: FI = -8.4371 + (55447.2 + 8.4371) / ((1 + (Conc / 4.39396)^-0.32952))^10 
 
FitProb. = 0.0000, ResVar. = 11.1243 
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Regression Type: Logistic - 5PL 
 
Std. Curve: FI = -14.4849 + (6713.82 + 14.4849) / ((1 + (Conc / 5247.42)^-2.4433))^0.37529 
 
FitProb. = 0.4400, ResVar. = 0.5962 
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